Home » Venture Capital » All Companies

All Companies

Company Description Statussort icon Initial Date
<a href="/venture-capital/all-companies/aerodesigns-inc">AeroDesigns Inc.</a> Pioneering air-based delivery systems to reimagine the consumption of food, nutrients and medications. Private 2011 View Profile
<a href="/venture-capital/all-companies/blend-therapeutics-inc">Blend Therapeutics Inc.</a> Discovering new classes of medicines that have unique modes of action to result in drugs with differentiated therapeutic properties. Private 2012 View Profile
<a href="/venture-capital/all-companies/tangent-medical-technologies-inc">Tangent Medical Technologies Inc.</a> Tangent Medical Technologies is advancing infusion therapy by improving catheter stability, patient comfort and healthcare worker safety with its proprietary, intravenous catheters and associated products. Private 2011 View Profile
<a href="/venture-capital/all-companies/syros-pharmaceuticals-0">Syros Pharmaceuticals</a> Life sciences company harnessing breakthroughs in gene control to revolutionize the treatment of cancer and other diseases. Private 2012 View Profile
<a href="/venture-capital/all-companies/aveo-pharmaceuticals-inc">AVEO Pharmaceuticals, Inc.</a> Discovering, developing and commercializing cancer therapeutics. Public 2003 View Profile
<a href="/venture-capital/all-companies/bg-medicine-inc">BG Medicine, Inc.</a> Novel diagnostics to improve patient outcomes and contain healthcare costs. Public 2000 View Profile
<a href="/venture-capital/all-companies/helicos-biosciences-corporation">Helicos BioSciences Corporation</a> Innovative genetic analysis technologies for the development and marketing of molecular diagnostics tests. Public 2003 View Profile
<a href="/venture-capital/all-companies/zalicus">Zalicus</a> Discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases. Public 2002 View Profile
<a href="/venture-capital/all-companies/receptos-inc">Receptos, Inc.</a> Developing therapeutic candidates for the treatment of immune and metabolic diseases. Public 2009 View Profile
<a href="/venture-capital/all-companies/tetraphase-pharmaceuticals-inc">Tetraphase Pharmaceuticals, Inc.</a> Creating novel antibiotics for serious and life-threatening multi-drug resistant infections. Public 2006 View Profile
<a href="/venture-capital/all-companies/adolor-corporation">Adolor Corporation</a> Discovery, development and commercialization of prescription pain management products Public 1996 View Profile
<a href="/venture-capital/all-companies/insmed-incorporated">INSMED, Incorporated</a> Pharmaceuticals for treatment of metabolic diseases and endocrine disorders Public 1996 View Profile
<a href="/venture-capital/all-companies/idexx-laboratories">IDEXX Laboratories</a> Products that enhance the ability of veterinarians to economically provide advanced medical care Public 1991 View Profile
<a href="/venture-capital/all-companies/cytyc">CYTYC</a> Design, development, manufacturing, and marketing of medical devices focused on women's health Public 1989 View Profile
<a href="/venture-capital/all-companies/antigenics">Antigenics</a> Technology and products to treat cancers, infectious diseases, and autoimmune disorders Public 1994 View Profile
<a href="/venture-capital/all-companies/celera">Celera</a> Sequenced human genome; now focused on therapeutics for cancer and other diseases Public 1998 View Profile
<a href="/venture-capital/all-companies/exact-sciences">EXACT Sciences</a> Proprietary technologies for the early detection, monitoring and staging of common cancers Public 1995 View Profile
<a href="/venture-capital/all-companies/renovis">Renovis</a> Discovery, development and commercialization of druts to treat neurological diseases and disorders Public 2000 View Profile
<a href="/venture-capital/all-companies/adnexus-therapeutics">Adnexus Therapeutics</a> Developing new class of therapeutic compounds. Acquired 2002 View Profile
<a href="/venture-capital/all-companies/visen-medical-inc">VisEn Medical, Inc.</a> Pioneering a new era of in vivo imaging. Acquired 2005 View Profile